GlobeNewsWire
21 Apr 2026, 20:05 UTC · 22w ago
Verdict
Headline takes no side. We score FHTX +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
FHD-909 showed complete and durable tumor regression and anti-tumor immune memory when combined with an anti-PD-1 antibody in preclinical mouse models.
More positive than 93% of claims this week
Foghorn's selective EP300 degrader outperformed existing clinical benchmarks in preclinical multiple myeloma models regarding safety and efficacy.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 87% of claims this week
The selective CBP degrader FHT-171 demonstrated strong anti-tumor activity and favorable tolerability in preclinical models of heavily pretreated ER+ breast cancer.
More positive than 78% of claims this week
The company achieved robust degradation with cereblon-based selective ARID1B degraders designed for potential oral bioavailability.
More positive than 65% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company presented positive preclinical data showing tumor regression and efficacy across multiple oncology programs.
More positive than 60% of ticker scores this week
Lilly is collaborating on the FHD-909 program which showed positive preclinical results.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
6h ago
−33.6%
Price is moving against the score
$3.50 vs $5.27 close before publication (Apr 21) · not market-adjusted
FHTX chart →
